Bayesian decision theory can be used not only to estab-lish the optimal sample size and its allocation in a single clinical study but also to identify an optimal portfolio of research combining different types of study design. Within a single study, the highest societal payoff to proposed research is achieved when its sample sizes and allocation between available treatment options are chosen to maximize the expected net benefit of sampling (ENBS). Where a number of different types of study informing different parameters in the decision problem could be conducted, the simultaneous estimation of ENBS across all dimensions of the design space is required to identify the optimal sample sizes and alloca-tions within such a research portfolio. Th...
Many situations require careful selection of information. Appropriate medical tests can improve diag...
Current practice for sample size computations in clinical trials is largely based on frequentist or ...
It is common for a number of potentially effective treatments to be available for clinical evaluatio...
Bayesian decision theory can be used not only to estab-lish the optimal sample size and its allocati...
Bayesian decision theory can be used not only to establish the optimal sample size and its allocatio...
Sample size determination (SSD) is a key issue in medical study design – in some cases (i.e. a RCT) ...
A decision maker confronted with the task of designing a clinical trial has to consider a multitude ...
This article describes an approach to optimal design of phase II clinical trials using Bayesian deci...
International audiencePilot studies and other small clinical trials are often conducted but serve a ...
The Design Space (DS) is defined as the set of factors settings (input conditions) that provides res...
If the prospective evaluation of all feasible strategies of patient management is not possible or ef...
One of the most important questions in the planning of medical experiments to assess the performance...
Value of Information (VOI) methods are based on Bayesian decision theory and provide decision makers...
Rapid progress in biomedical research necessitates clinical evaluation that identifies promising inn...
The clinical trials that provide evidence for new cancer treatments often fall sort of providing ade...
Many situations require careful selection of information. Appropriate medical tests can improve diag...
Current practice for sample size computations in clinical trials is largely based on frequentist or ...
It is common for a number of potentially effective treatments to be available for clinical evaluatio...
Bayesian decision theory can be used not only to estab-lish the optimal sample size and its allocati...
Bayesian decision theory can be used not only to establish the optimal sample size and its allocatio...
Sample size determination (SSD) is a key issue in medical study design – in some cases (i.e. a RCT) ...
A decision maker confronted with the task of designing a clinical trial has to consider a multitude ...
This article describes an approach to optimal design of phase II clinical trials using Bayesian deci...
International audiencePilot studies and other small clinical trials are often conducted but serve a ...
The Design Space (DS) is defined as the set of factors settings (input conditions) that provides res...
If the prospective evaluation of all feasible strategies of patient management is not possible or ef...
One of the most important questions in the planning of medical experiments to assess the performance...
Value of Information (VOI) methods are based on Bayesian decision theory and provide decision makers...
Rapid progress in biomedical research necessitates clinical evaluation that identifies promising inn...
The clinical trials that provide evidence for new cancer treatments often fall sort of providing ade...
Many situations require careful selection of information. Appropriate medical tests can improve diag...
Current practice for sample size computations in clinical trials is largely based on frequentist or ...
It is common for a number of potentially effective treatments to be available for clinical evaluatio...